349 related articles for article (PubMed ID: 28177161)
1. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
[TBL] [Abstract][Full Text] [Related]
2. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in bone resorption regulated by vitamin D.
Nakamichi Y; Udagawa N; Suda T; Takahashi N
J Steroid Biochem Mol Biol; 2018 Mar; 177():70-76. PubMed ID: 29146302
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control.
Yamamoto Y; Yoshizawa T; Fukuda T; Shirode-Fukuda Y; Yu T; Sekine K; Sato T; Kawano H; Aihara K; Nakamichi Y; Watanabe T; Shindo M; Inoue K; Inoue E; Tsuji N; Hoshino M; Karsenty G; Metzger D; Chambon P; Kato S; Imai Y
Endocrinology; 2013 Mar; 154(3):1008-20. PubMed ID: 23389957
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis.
Yang R; Chen J; Zhang J; Qin R; Wang R; Qiu Y; Mao Z; Goltzman D; Miao D
Aging Cell; 2020 Feb; 19(2):e13095. PubMed ID: 31880094
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
[TBL] [Abstract][Full Text] [Related]
8. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
9. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
Takahashi N
J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
[TBL] [Abstract][Full Text] [Related]
11. Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.
Hirota Y; Nakagawa K; Isomoto K; Sakaki T; Kubodera N; Kamao M; Osakabe N; Suhara Y; Okano T
PLoS One; 2018; 13(10):e0199856. PubMed ID: 30281599
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
[TBL] [Abstract][Full Text] [Related]
13. Identification of the vitamin D receptor in osteoblasts and chondrocytes but not osteoclasts in mouse bone.
Wang Y; Zhu J; DeLuca HF
J Bone Miner Res; 2014 Mar; 29(3):685-92. PubMed ID: 24038189
[TBL] [Abstract][Full Text] [Related]
14. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
[TBL] [Abstract][Full Text] [Related]
17. Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor.
Yashiro M; Ohya M; Mima T; Nakashima Y; Kawakami K; Yamamoto S; Kobayashi S; Yano T; Tanaka Y; Sonou T; Tatsuta K; Negi S; Shigematsu T
J Pharm Biomed Anal; 2020 Apr; 182():113139. PubMed ID: 32045827
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.
Lam NN; Triliana R; Sawyer RK; Atkins GJ; Morris HA; O'Loughlin PD; Anderson PH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():128-31. PubMed ID: 24434283
[TBL] [Abstract][Full Text] [Related]
20. [Frontiers in vitamin D; basic research and clinical application. Is VDR a factor of bone volume regulator in bone tissues?].
Kato S; Yamamoto Y
Clin Calcium; 2011 Nov; 21(11):45-52. PubMed ID: 22040820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
